• Radiotherapy in China | Techniques, Duration & Cost

    Radiotherapy in China | Techniques, Duration & Cost

    Radiotherapy in China | Techniques, Duration & Cost

     

     

    Radiotherapy uses precisely targeted radiation to destroy cancer cells. It can cure some cancers on its own, work alongside surgery or chemotherapy, or relieve symptoms. Radiotherapy and radiation therapy refer to the same cancer treatment.

    Radiation oncology departments in China’s top cancer centres and university hospitals offer: modern external beam techniques including IMRT, VMAT and image-guided radiotherapy (IGRT) stereotactic radiotherapy and radiosurgery brachytherapy (internal radiotherapy) proton and carbon ion therapy, available at a small number of specialised particle centres

    For international patients, the most practical question is usually how long treatment takes. Many modern regimens in China use shorter hypofractionated schedules supported by clinical evidence: accelerated partial breast or whole-breast hypofractionated radiotherapy after surgery is widely adopted for suitable patients some small primary tumours or oligometastases can be treated in 1–5 stereotactic sessions other curative-intent cancers still require 5–7 weeks of daily treatment

    Approximate prices for a full course of conventional photon radiotherapy for breast or prostate cancer in international medical tracks are around ¥120,000 to ¥200,000. Proton and carbon ion therapy packages at the Shanghai Proton and Heavy Ion Center are a fixed package price of ¥278,000 per single course, while domestic proton centres may offer lower pricing for selected indications

    This guide explains the main radiotherapy techniques, typical treatment timelines, the role of proton and carbon ion therapy, estimated costs and practical tips for international patients planning a stay in China.

    How Radiotherapy Works and When Is It Used?

    Radiation damages the DNA of cancer cells so they can no longer divide and grow. Healthy cells are also affected, yet they repair radiation damage much more effectively. This is why treatment is split into many small daily doses called fractions.

    Radiotherapy may be used: as the primary curative treatment, for example for nasopharyngeal carcinoma, some prostate, head and neck, cervical, lung and skin cancers before surgery (neoadjuvant), to shrink tumours, for example in rectal or oesophageal cancer after surgery (adjuvant), to lower recurrence risk, for example after breast-conserving surgery or cervical cancer surgery combined with chemotherapy (chemoradiotherapy), to boost anti-tumour effect for palliative symptom control, such as pain from bone metastases, bleeding, or nerve and spinal cord compression

    Types of Radiotherapy

    External beam radiotherapy

    A linear accelerator delivers high-energy X-ray photons to the tumour from outside the body. This is the most common form of radiotherapy in China. Most modern treatment combines these techniques: IMRT (intensity-modulated radiotherapy) shapes the radiation dose tightly around the tumour, reducing radiation exposure to adjacent organs. VMAT (volumetric modulated arc therapy) is a rotational form of IMRT, usually faster per treatment session. IGRT (image-guided radiotherapy) uses on-board imaging before each fraction to verify tumour position and correct minor movement shifts.

    IMRT, VMAT and IGRT are not separate premium treatments. They are standard components of modern radiotherapy in major tertiary cancer centres across China.

    Stereotactic radiotherapy

    Stereotactic treatment delivers a high, highly focused radiation dose to a small, well-defined tumour target in one to a few sessions.

    Stereotactic radiosurgery (SRS) treats brain metastases, selected benign brain tumours such as meningiomas and vestibular schwannomas, and arteriovenous malformations. It is often delivered in a single session. Despite the name, no surgical incision is required. Systems include Gamma Knife, CyberKnife and advanced linear accelerator platforms.

    Stereotactic body radiotherapy (SBRT / SABR) treats small tumours outside the brain, typically in 1–5 fractions. Common indications include early-stage lung cancer in patients unfit for surgery, selected liver tumours, spinal metastases, limited oligometastatic disease, and carefully selected prostate cancer patients.

    For stereotactic therapy, the clinical experience of the oncology team with your tumour type matters more than the brand name of the equipment.

    Brachytherapy (internal radiotherapy)

    A sealed radioactive source is placed inside or next to the tumour, delivering a high local dose that falls off rapidly in surrounding normal tissue. It is an essential part of treatment for: cervical cancer (often combined with external beam radiotherapy) selected prostate cancers vaginal and some endometrial cancers selected breast, skin and oesophageal cancers

    Proton and carbon ion (particle) therapy

    Protons deposit most of their energy at a defined depth and stop immediately afterwards, lowering dose to healthy tissue behind the tumour. Carbon ions are heavier particles with stronger biological killing effect, used for certain tumours that are resistant to conventional photon radiotherapy. Particle therapy is covered in more detail below.

    Radionuclide (systemic) therapy

    Radioactive medicines are given orally or via injection and travel to cancer cells. Examples include radioactive iodine for thyroid cancer and targeted radioligand therapies for selected prostate and neuroendocrine tumours. These are usually delivered by nuclear medicine departments rather than radiotherapy units.

    How Long Does Radiotherapy Take?

    Treatment duration is often the key deciding factor for international patients. The number of sessions depends on cancer type, treatment goal and selected technique.

    表格

    Situation Typical number of sessions Approximate treatment period
    Single brain metastasis or benign brain tumour (SRS) 1–5 1 day to 1 week
    Early lung cancer, oligometastases, liver or spine lesions (SBRT) 1–8 1–2 weeks
    Whole-breast hypofractionated radiotherapy after breast conservation 5 or 15 1 or 3 weeks
    Prostate cancer (external beam) 5 (selected patients) to 20–39 1–8 weeks
    Palliative radiotherapy for painful bone metastases 1–10 1 day to 2 weeks
    Head and neck / nasopharyngeal cancer (often concurrent chemotherapy) Around 30–35 6–7 weeks
    Cervical cancer (EBRT plus brachytherapy, often with chemotherapy) Around 25–30 plus brachytherapy 6–8 weeks
    Rectal cancer preoperative radiotherapy 5 or 25–28 1 or 5–6 weeks

    Treatment is usually given once daily, Monday to Friday, as an outpatient. Most international patients stay in nearby accommodation rather than in hospital. You should reserve extra time before treatment starts for consultation, simulation CT and plan preparation, which generally takes 1–2 weeks.

    Shorter hypofractionated schedules are widely used in China based on international clinical trial data. For suitable early breast cancer patients, one-week 5-fraction whole-breast radiotherapy offers equivalent local control and similar late toxicity compared with traditional 3-week regimens. Ask the Chinese radiation oncology team whether an accelerated schedule is suitable for your case and confirm your exact required stay length.

    Proton and Carbon Ion Therapy in China: Who Benefits?

    Proton therapy is frequently searched by international patients, yet it is not the optimal option for everyone.

    Clinical scenarios where particle therapy has the strongest rationale: children and adolescents, where reducing radiation to growing tissues lowers long-term side effects and second cancer risk tumours at the skull base and along the spinal axis, such as chordomas and chondrosarcomas selected brain tumours and ocular tumours including uveal melanoma re-irradiation cases, and tumours adjacent to critical structures such as optic nerves or brainstem

    Scenarios where the advantage is less clear: for many common adult cancers including most prostate and breast cancers, modern IMRT photon radiotherapy achieves comparable cancer control outcomes. Proton therapy is not clearly superior for these groups.

    For locally advanced head and neck cancer, published phase III data shows similar tumour control between proton therapy and IMRT photon radiotherapy, with fewer severe side effects such as feeding tube dependence in the proton arm for properly selected patients.

    Cost and availability

    The Shanghai Proton and Heavy Ion Center (SPHIC) applies a fixed single-course package price of ¥278,000 for proton or carbon ion therapy, covering simulation, planning and the full radiotherapy course for one target lesion. New domestic proton centres offer lower pricing for eligible patients.

    Particle therapy centres in China

    表格

    Centre City Modalities
    Shanghai Proton and Heavy Ion Center (SPHIC) Shanghai Protons and carbon ions, the most mature centre accepting international patients
    Gansu Wuwei Heavy Ion Center Wuwei Carbon ion therapy
    Guangzhou Concord Cancer Center Guangzhou Proton therapy
    Wuhan Tongji Proton Center Wuhan Proton therapy

    Side Effects of Radiotherapy

    Side effects depend mainly on the treated region, total dose and fraction schedule. Most acute side effects start during treatment and gradually resolve within weeks after completion.

    表格

    Treated area Common short-term side effects
    Any treated region Fatigue, skin redness and irritation in the radiation field
    Head and neck / nasopharynx Sore mouth and throat, dysphagia, dry mouth, taste disturbance
    Brain Tiredness, local hair loss, headache
    Chest Painful swallowing, cough
    Breast Skin erythema, breast swelling
    Abdomen and pelvis Diarrhoea, bladder irritation, nausea

    Late effects can appear months or years after treatment. They are site-dependent and may include: persistent dry mouth skin and soft tissue fibrosis bowel or bladder function changes fertility impact rarely, secondary malignancy

    External beam radiotherapy does not make you radioactive. Permanent brachytherapy implants and systemic radionuclide therapy require short-term radiation safety precautions, which your care team will explain clearly.

    What Radiotherapy in China Involves for International Patients?

    Remote medical review. Submit pathology reports, full DICOM imaging and prior treatment history. A radiation oncologist or MDT panel reviews your case and advises whether radiotherapy is appropriate, which technique to use and the projected number of fractions.

    In-person consultation and informed consent. You meet the radiation oncologist in China to confirm the final plan and discuss expected side effects.

    Simulation CT (treatment planning scan). A CT scan is acquired in your exact treatment position; custom masks, cushions or immobilisation shells are made to maintain reproducibility. MRI or PET/CT images are fused to the planning scan for precise contouring. Small skin marks may be placed for alignment.

    Treatment planning. Medical physicists and oncologists design and verify the dose plan, which usually takes several working days.

    Treatment delivery. Each session typically takes 10–30 minutes, with most time spent on patient positioning. Weekly on-treatment reviews monitor side effects.

    Treatment completion and handover. You receive a formal treatment summary with dose parameters and treated target volumes. This document is critical if you need radiotherapy anywhere else in the future.

    Combined therapy. If radiotherapy is given with chemotherapy, both modalities are usually delivered at the same centre for the full course.

    Choosing a Hospital for Radiotherapy in China

    When selecting a centre, check that it provides: proven multidisciplinary experience with your cancer type and the recommended technique MDT tumour board meetings, ideally within a nationally certified cancer centre on-site brachytherapy capability if your treatment requires it (e.g. cervical cancer) stereotactic expertise for brain or body SBRT/SRS access to proton or carbon ion therapy only if your tumour type is known to benefit from particle therapy an international patient office that can provide written cost estimates, translation support and accommodation assistance

    Major cancer centres and university-affiliated hospitals in Beijing, Shanghai, Guangzhou and other large cities have established radiation oncology departments with international patient services.

    Cost of Radiotherapy in China

    There is no universal fixed price. The final cost varies by cancer diagnosis, technique, number of fractions, concurrent chemotherapy and hospital international track pricing. General reference ranges: a full curative course of conventional IMRT/VMAT radiotherapy for breast or prostate cancer: approximately ¥120,000–¥200,000 proton or carbon ion therapy at SPHIC: fixed ¥278,000 per single course for one target

    Shorter stereotactic or palliative courses generally cost less than full curative regimens.

    Factors that change total cost

    表格

    Cost component Source of variation
    Treatment technique Photon IMRT / VMAT, SBRT, brachytherapy, proton or carbon ion
    Number of fractions 1–5 for stereotactic plans, up to 35–39 for some radical courses
    Planning and imaging Simulation CT, MRI/PET fusion, replanning if tumour anatomy changes
    Concurrent chemotherapy Drug costs and regular monitoring
    Anaesthesia Required for some brachytherapy procedures and paediatric cases
    Supportive care Nutrition support, anti-inflammatory or symptomatic management
    Non-medical expenses Accommodation for the whole treatment period, companion stay, interpreters, travel and visa

    For multi-week daily radiotherapy, accommodation can form a substantial part of your total budget. Ask the hospital international office about patient housing or nearby serviced apartments.

    Insurance

    Some international health insurers cover radiotherapy overseas, subject to prior authorisation. Confirm coverage in writing before travel, especially for proton and carbon ion therapy.

    How International Patients Can Prepare

    Medical documents to collect

    Pathology report confirming tumour histology and subtype. Full DICOM imaging files (CT, MRI, PET/CT), not only written reports. Operation notes if you have received surgery. Previous radiotherapy records with dose and treated volume details — mandatory if you have had prior radiation. Chemotherapy and systemic treatment history. Current medication list including anticoagulants and comorbidities. Details of implanted devices such as pacemakers that may affect planning.

    Records not in English or Chinese will need certified translation.

    Travel and administrative documents

    M visa (medical visa). Most non-Chinese citizens require a medical M visa for cancer treatment. Longer treatment courses or combined chemo-radiotherapy may require longer-term visa arrangements. Applications usually require the hospital invitation letter, formal cost estimate, proof of funds and valid health insurance.

    Other arrangements: proof of funds or insurer guarantee of payment long-term accommodation close to the hospital a companion, especially for longer courses or concurrent chemoradiotherapy

    Questions to Ask Your Radiation Oncologist

    What is the goal of radiotherapy for my case: cure, lowering recurrence risk, or palliative symptom relief? Which technique do you recommend, and why? How many fractions will I need, and is a shorter hypofractionated schedule suitable? How long do I need to stay in China, including planning time? Will proton or carbon ion therapy offer a meaningful advantage over photon radiotherapy for me? Will chemotherapy be given at the same time? What side effects should I expect during treatment and in the long term? How will side effects be managed after I return home? What follow-up scans will I need and when? Will I receive a full written radiotherapy summary with dose and volume information? What is included and excluded from the cost estimate?

    Recovery After Radiotherapy

    Fatigue often builds gradually during treatment and may persist for several weeks after finishing. Skin reactions and other acute side effects usually improve 2–4 weeks after the last fraction, though recovery may take longer for some patients.

    Practical care guidance: only use skin products approved by your radiation team on the treated area and protect it from direct sun wear loose, soft clothing over the radiation field maintain adequate nutrition and fluid intake, especially for head and neck or pelvic radiotherapy keep gentle physical activity as tolerated to reduce fatigue seek urgent medical help for worsening pain, swallowing difficulty, fever, bleeding or severe diarrhoea

    Follow-up assessment. Tumour shrinkage often continues for weeks to months after radiotherapy ends, so response scans are scheduled after a waiting period. Most follow-up can be done locally in your home country, with results shared back to your Chinese treating team.

    Frequently Asked Questions

    1. How much does radiotherapy cost in China? Cost depends on technique and fraction count. A full conventional photon radiotherapy course for breast or prostate cancer is around ¥120,000–¥200,000. Proton and carbon ion therapy at SPHIC is ¥278,000 per single course. Short stereotactic or palliative courses are generally cheaper.
    2. How long do I need to stay in China for radiotherapy? SRS can be completed within days to one week. Many radical courses require 3–7 weeks of daily treatment. Add 1–2 weeks upfront for consultation and simulation planning.
    3. Is proton therapy better than normal radiotherapy? Not for everyone. Proton therapy has clear advantages for children, skull base and spinal tumours, selected brain and eye tumours, and re-irradiation near critical organs. For many common adult cancers such as most breast and prostate cancers, modern IMRT photon radiotherapy achieves comparable tumour control at lower cost.
    4. Where is proton and carbon ion therapy available in China? Shanghai Proton and Heavy Ion Center (SPHIC) offers both proton and carbon ion. Additional proton centres operate in Guangzhou, Wuhan and other cities; Wuwei provides carbon ion therapy.
    5. What is the difference between SRS and SBRT? Both deliver high precise doses in one or a few sessions. Stereotactic radiosurgery (SRS) targets intracranial lesions in the brain, while SBRT treats small tumours elsewhere in the body such as lung, liver and spine.
    6. Can breast radiotherapy be completed in one week? Yes, for properly selected patients after breast-conserving surgery. Hypofractionated 5-fraction whole-breast radiotherapy is standard in China for eligible women, with equivalent long-term local control and similar late side effects. Your oncologist will confirm eligibility.
    7. Is radiotherapy painful? No. The treatment itself is painless, and each irradiation segment takes only a few minutes. Side effects such as skin soreness and fatigue may develop over the course of treatment.
    8. Will I be radioactive after treatment? Not after external beam radiotherapy. Selected brachytherapy implants and systemic radionuclide therapy require temporary radiation safety precautions.
    9. Can I get a radiotherapy plan before travelling to China? Yes. Chinese cancer centres can review your medical records remotely and provide a second opinion, proposed technique, fraction count and cost estimate. The final personalised plan is made after simulation CT once you arrive.
    10. Can I have radiotherapy again if I received radiation before? Sometimes. It depends on prior dose distribution, the overlapping normal tissue, and the interval since the previous course. Complete prior radiotherapy records are mandatory for re-irradiation planning.

    Sources Chinese Society for Radiation Oncology (CSRO) clinical guidelines Shanghai Proton and Heavy Ion Center official public information Major Chinese cancer centre radiotherapy protocols FAST-Forward trial data for breast hypofractionated radiotherapy Published phase III proton vs IMRT head and neck trial data

    Read more
  • Thyroid Cancer Treatment in Zhejiang – CMS Guide

    Thyroid Cancer Treatment in Zhejiang – CMS Guide

    Overview

    Zhejiang hosts top-tier tertiary hospitals with mature, multidisciplinary thyroid cancer programs, covering conventional thyroid surgery, scarless endoscopic minimally invasive procedures, locally advanced/recurrent thyroid carcinoma, thermal ablation, radioiodine therapy, and long-term endocrine surveillance. For international patients seeking a second opinion, surgical consultation or definitive thyroid cancer treatment, this guide from CMS helps you select the appropriate hospital, department and specialist matched to your clinical condition and cosmetic expectations.

    How to Choose the Right Specialist

    1. Standard Thyroid Cancer Surgery

    For uncomplicated papillary or follicular thyroid cancer requiring total thyroidectomy or hemithyroidectomy with or without central neck dissection, thyroid surgery teams at The First Affiliated Hospital of Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, and Zhejiang Cancer Hospital deliver high-volume, standardized care with nationally recognized protocols. Recommended specialists: Dr. Wu Yijun, Chief Physician, Director of Thyroid Surgery, The First Affiliated Hospital of Zhejiang University Specializes in thyroid and parathyroid surgery, pioneer of the sternocleidomastoid intermuscular approach for anterior cervical functional preservation, high-volume routine thyroid cancer resection and neck dissection. Dr. Dong Shuai, Chief Physician, Deputy Director of Thyroid Surgery, The First Affiliated Hospital of Zhejiang University Expert in standard thyroid cancer surgery, giant goiter, low-risk papillary microcarcinoma, and recurrent thyroid disease with nerve reconstruction for voice protection. Dr. Gao Li, Chief Physician, Head and Neck Surgery, Sir Run Run Shaw Hospital Focuses on standardized differentiated thyroid cancer surgery, functional neck dissection, and minimally invasive thyroid surgery, Vice Chairman of Zhejiang Thyroid Cancer Committee. Dr. Lan Xiabin, Chief Physician, Associate Professor, Thyroid Surgery, Zhejiang Cancer Hospital Specializes in standard thyroid oncologic resection, lymph node staging, parathyroid surgery, and post-operative long-term endocrine management; completed postdoctoral training in the United States.

    2. Complex or Locally Advanced Thyroid Cancer

    For tumours invading trachea, esophagus or cervical vessels, massive goiter, recurrent disease, or cases requiring neoadjuvant targeted therapy before surgery, subspecialty head-and-neck oncology expertise is critical. Recommended specialists: Dr. Zhao Jianqiang, Chief Physician, Deputy Director of Head and Neck Surgery, Zhejiang Cancer Hospital Leading expert for locally advanced thyroid cancer with tracheal/oesophageal invasion, complex defect reconstruction, hereditary medullary thyroid cancer and prophylactic thyroid surgery. Dr. Zhang Deguang, Chief Physician, Deputy Director of Head and Neck Surgery, Sir Run Run Shaw Hospital Specializes in recurrent thyroid cancer, advanced disease with mediastinal lymph node metastasis, combined thoracic-head-neck surgery, and multi-organ resection & reconstruction. Dr. Wang Wendong, Chief Physician, Thyroid Surgery, Zhejiang Cancer Hospital Experienced in reoperation for recurrent thyroid cancer, lateral neck dissection, and tumours invading aerodigestive tract structures. Dr. Chen Chao, Chief Physician, Director of Head and Neck Surgery, Zhejiang Cancer Hospital Focuses on multidisciplinary management of advanced thyroid carcinoma, neoadjuvant targeted therapy, and complex post-resection functional reconstruction.

    3. Scarless / Minimally Invasive Endoscopic Thyroid Surgery

    For patients prioritizing cosmetic outcomes and avoiding visible neck scars, Zhejiang centres offer mature endoscopic routes including transoral, transareolar, transaxillary and subclavicular approaches. Recommended specialists: Dr. Zhang Deguang, Chief Physician, Deputy Director of Head and Neck Surgery, Sir Run Run Shaw Hospital Pioneer of airless scarless endoscopic thyroid surgery; proficient in transoral, transaxillary, subclavicular and transbreast approaches, with large experience in endoscopic lateral neck dissection. Dr. Shen Haibin, Associate Chief Physician, Thyroid Surgery, The First Affiliated Hospital of Zhejiang University Performs scarless endoscopic thyroidectomy via axillary and subclavicular routes, alongside minimally invasive open surgery and thyroid ablation. Dr. Wang Wendong, Chief Physician, Thyroid Surgery, Zhejiang Cancer Hospital Offers transoral, transareolar and transaxillary endoscopic thyroid cancer surgery with emphasis on recurrent laryngeal nerve and parathyroid protection. Dr. Peng You, Chief Physician, Deputy Director of Thyroid Surgery, Hangzhou First People’s Hospital Specializes in transoral vestibular, transaxillary and full-areola scarless endoscopic thyroidectomy, functional-preserving neck dissection.

    4. Thyroid Ablation (Non-Surgical Option)

    For suitable patients with benign thyroid nodules or low-risk papillary thyroid microcarcinoma (≤1 cm) who wish to avoid surgery, thermal ablation (radiofrequency / microwave ablation) is an outpatient incision-free option with same-day discharge. Recommended specialists: Dr. Shen Haibin, Associate Chief Physician, Thyroid Surgery, The First Affiliated Hospital of Zhejiang University Performs ultrasound-guided radiofrequency ablation for benign nodules and selected low-risk papillary microcarcinoma. Dr. Jiang Tian’an, Chief Physician, Director of Ultrasound Department, The First Affiliated Hospital of Zhejiang University National leading expert in interventional ultrasound, thyroid ablation, and image-guided minimally invasive treatment for selected thyroid lesions.

    5. Post-Operative Endocrine Management

    After thyroid cancer surgery, continuous endocrine follow-up is essential for long-term disease control, including radioactive iodine (RAI) ablation, levothyroxine TSH suppression, serial thyroglobulin and antibody monitoring. It is recommended to coordinate care with endocrinologists specialized in thyroid cancer surveillance. When selecting a surgical hospital, confirm that the centre has strong endocrinology and nuclear medicine capacity for post-surgical RAI therapy.

    Which Department to Book

    When scheduling thyroid cancer consultations in Zhejiang, use these official department names: Thyroid Surgery  — The First Affiliated Hospital of ZJU Head and Neck Surgery — Sir Run Run Shaw Hospital, Zhejiang Cancer Hospital Thyroid Surgery  — Zhejiang Cancer Hospital Thyroid Specialized Clinic — widely available across major tertiary hospitals

    What to Bring to Your Appointment

    Neck ultrasound report with TI-RADS / C-TIRADS classification and full measurements of all nodules and suspicious lymph nodes FNA cytopathology report with Bethesda classification, if fine-needle aspiration has been completed Available molecular testing results: BRAF V600E, RET, RAS mutations, TERT promoter mutation status Contrast-enhanced neck and chest CT scan (for locally advanced, invasive or metastatic disease) Thyroid function panel: TSH, free T4, free T3 Tumor markers: thyroglobulin (Tg), anti-Tg antibody; calcitonin and CEA for suspected medullary thyroid cancer Previous operative notes, RAI records or targeted therapy documentation for patients with prior treatment history Laryngoscopy report, if you have hoarseness or voice impairment

    Questions to Ask Your Specialist

    Do you routinely manage my specific thyroid cancer subtype (papillary, follicular, medullary, anaplastic)? For my case, would you recommend total thyroidectomy or hemithyroidectomy, and what is the rationale? Given my tumor size and lymph node status, am I a suitable candidate for minimally invasive or scarless endoscopic surgery? Will I need radioactive iodine ablation after surgery, and how will the nuclear medicine treatment be arranged? Is multidisciplinary tumor board review advised for my diagnosis? What is your annual caseload of thyroid cancer operations?

    How CMS Can Help

    CMS supports international patients navigating thyroid cancer care across top hospitals in Zhejiang, matching each patient to the most appropriate specialist according to cancer subtype, clinical complexity and cosmetic preferences. Our dedicated services include: Remote case evaluation and specialist matching before you travel to China Priority appointment booking with selected surgeons at leading Zhejiang medical centers Full professional translation of ultrasound, pathology, genetic testing reports and treatment plans On-site hospital accompaniment by English-speaking patient care coordinators Logistics support including accommodation arrangement and local transfer services within Zhejiang Post-discharge follow-up and remote consultation support after you return to your home country

    Read more